etoposide has been researched along with Down Syndrome in 30 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (3.33) | 18.7374 |
| 1990's | 3 (10.00) | 18.2507 |
| 2000's | 14 (46.67) | 29.6817 |
| 2010's | 12 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shand, JC | 1 |
| Adachi, JI; Mishima, K; Miyake, Y; Nishikawa, R; Sasaki, A; Suzuki, T | 1 |
| Eisenman, K; Maloney, KW; Ross, S | 1 |
| Adachi, S; Goto, H; Horibe, K; Ito, E; Iwamoto, S; Kinoshita, A; Koh, K; Kudo, K; Moritake, H; Nakahata, T; Nakayama, H; Saito, AM; Shimada, A; Taga, T; Takahashi, H; Taki, T; Tawa, A; Terui, K; Toki, T; Tomizawa, D; Watanabe, T | 1 |
| Bochennek, K; Creutzig, U; Gilfert, J; Hassler, A; Lehrnbecher, T; Perner, C; Reinhardt, D; Schöning, S | 1 |
| Adachi, S; Arakawa, Y; Funaki, T; Heike, T; Hiramatsu, H; Mizowaki, T; Nodomi, S; Saida, S; Ueno, H; Umeda, K | 1 |
| Aguilar-Ponce, JL; Chilaca-Rosas, F; Cruz-López, JC; Martínez-Cedillo, J; Molina-Calzada, C; Vidal-Millán, S | 1 |
| Campana, D; Crews, KR; Downing, JR; Gandhi, VV; Pounds, S; Pui, CH; Raimondi, SC; Razzouk, BI; Ribeiro, RC; Rubnitz, JE; Yang, S | 1 |
| Britt-Marie, F; Curt, P; Frost, BM; Gudmar, L; Hasle, H; Hellebostad, M; Henrik, H; Josefine, P; Jukka, K; Kanerva, J; Kjeld, S; Lönnerholm, G; Marit, H; Palle, J; Petersson, C; Schmiegelow, K | 1 |
| Domm, J; Eckrich, MJ; Frangoul, H; Ho, R; Whitlock, JA | 1 |
| Blasi, F; Castagnaro, L; Crippa, MP; Ferrai, C; Iotti, G; Longobardi, E; Micali, N; Ricciardi, M | 1 |
| Fujita, K; Fushimi, H; Hosomi, M; Kato, T; Nakazawa, S; Okumi, M; Takezawa, K; Tanigawa, G; Yamaguchi, S; Yoneda, S | 1 |
| Abe, M; Arai, J; Katayama, N; Kato, K; Kobayashi, C; Koike, K; Mouri, Y; Shiono, J; Tsuchida, M; Yanase, K; Yoshimi, A | 1 |
| Balci, TB; Berman, JN; Buck, SA; Dellaire, G; Dombkowski, AA; Edwards, H; Ge, Y; Matherly, LH; Taub, JW; Xavier, AC; Xie, C | 1 |
| Alonzo, TA; Arceci, RJ; Barnard, D; Gamis, AS; Gerbing, RB; Hathaway, L; Hilden, JM; Loew, TW; Ravindranath, Y; Smith, FO; Sorrell, AD; Taub, JW; Woods, WG | 1 |
| Fujii, M; Goto, H; Ideguchi, M; Nomura, S; Sadahiro, H; Sugimoto, K; Suzuki, M; Yoshikawa, K | 1 |
| Creutzig, U; Kaiser, J; Klingebiel, T; Lehrnbecher, T; Reinhardt, D; Varwig, D | 1 |
| Creutzig, U; Diekamp, S; Dworzak, M; Reinhardt, D; Stary, J; Zimmermann, M | 1 |
| de Graaf, SS; Gibson, BE; Hann, IM; Hills, RK; O'Marcaigh, A; Rao, A; Stiller, C; Webb, DK; Wheatley, K | 1 |
| Hanada, R; Kigasawa, H; Kinoshita, A; Tabuchi, K; Tomizawa, D; Tsuchida, M; Tsukimoto, I | 1 |
| Britt-Marie, F; Eva, L; Frost, BM; Göran, G; Gudmar, L; Gustafsson, G; Hellebostad, M; Jukka, K; Kanerva, J; Kjeld, S; Liliemark, E; Lönnerholm, G; Marit, H; Palle, J; Schmiegelow, K | 1 |
| Hamamoto, K; Hanada, R; Horibe, K; Imaizumi, M; Kigasawa, H; Kobayashi, R; Kojima, S; Kudo, K; Morimoto, A; Nakayama, H; Tabuchi, K; Tawa, A; Tsuchida, M; Tsukimoto, I; Yabe, H | 1 |
| Alfaro, E; Casak, S; Cygler, A; Felice, MS; Fraquelli, L; Gallego, M; Pérez, LE; Quinteros, R; Sackmann-Muriel, F; Zubizarreta, P | 1 |
| Readett, D; Richards, M; Vora, AJ; Watmore, A; Welch, J | 1 |
| Akiyama, Y; Eguchi, M; Hayashi, Y; Hosoi, G; Ishii, E; Kato, K; Koike, K; Kojima, S; Nishimura, S; Ohara, A; Okamura, J; Okimoto, Y; Sako, M; Sato, T; Tsukimoto, I; Ueda, K; Yazaki, M; Yoshikawa, T | 1 |
| Frost, BM; Gustafsson, G; Larsson, R; Lönnerholm, G; Nygren, P | 1 |
| Eksborg, S; Frostvik-Stolt, M; Liliemark, E; Lindberg, A; Söderhäll, S | 1 |
| Creutzig, U; de Vries, E; Hählen, K; Huismans, DR; Janka-Schaub, GE; Jansen, G; Kaspers, GJ; Peters, GJ; Pieters, R; Rots, MG; van Zantwijk, CH; Veerman, AJ; Zwaan, CM | 1 |
| Abella, E; Alvarado, CS; Chauvenet, A; Dubowy, R; Harris, M; Inoue, S; Krischer, JP; Ravindranath, Y; Ritchey, AK; Wiley, J | 1 |
| Brecher, ML; Freeman, AI; Green, DM; Sandberg, AA; Simon, JH; Tebbi, CK | 1 |
4 review(s) available for etoposide and Down Syndrome
| Article | Year |
|---|---|
Craniospinal Germinomas in Patient with Down Syndrome Successfully Treated with Standard-Dose Chemotherapy and Craniospinal Irradiation: Case Report and Literature Review.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Central Nervous System Neoplasms; Craniospinal Irradiation; Down Syndrome; Etoposide; Germinoma; Humans; Magnetic Resonance Imaging; Male; Neoplasms, Multiple Primary; Positron-Emission Tomography; Treatment Outcome | 2017 |
[A case of Down's syndrome associated with recurrent testicular tumor treated by chemotherapy successfully: review of 41 cases in Japanese literature].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Down Syndrome; Etoposide; Humans; Lymphatic Metastasis; Male; Seminoma; Testicular Neoplasms | 2010 |
Yolk sac tumor of the bilateral basal ganglia in a patient with Down syndrome.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Basal Ganglia; Brain Neoplasms; Chemoradiotherapy; Cisplatin; Disease Progression; Down Syndrome; Endodermal Sinus Tumor; Etoposide; Female; Humans; Ifosfamide; Magnetic Resonance Imaging; Paresis; Treatment Outcome | 2013 |
Acute megakaryoblastic leukemia associated with mosaic Down's syndrome.
Topics: Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 17; Clone Cells; Cyclophosphamide; Cytarabine; Down Syndrome; Doxorubicin; Etoposide; Female; Humans; Hydrocortisone; Infant; Leukemia, Megakaryoblastic, Acute; Methotrexate; Mosaicism; Prednisone; Thioguanine; Trisomy | 1987 |
10 trial(s) available for etoposide and Down Syndrome
| Article | Year |
|---|---|
Preserved High Probability of Overall Survival with Significant Reduction of Chemotherapy for Myeloid Leukemia in Down Syndrome: A Nationwide Prospective Study in Japan.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Down Syndrome; Doxorubicin; Etoposide; Female; Humans; Induction Chemotherapy; Infant; Japan; Kaplan-Meier Estimate; Leukemia, Myeloid; Male; Prospective Studies | 2016 |
Infectious Complications in Children With Acute Myeloid Leukemia and Down Syndrome: Analysis of the Prospective Multicenter Trial AML-BFM 2004.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Daunorubicin; Down Syndrome; Etoposide; Female; Humans; Idarubicin; Infant; Infections; Leukemia, Myeloid, Acute; Male; Mitoxantrone | 2016 |
Combination of cladribine and cytarabine is effective for childhood acute myeloid leukemia: results of the St Jude AML97 trial.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Cladribine; Combined Modality Therapy; Cytarabine; Daunorubicin; Down Syndrome; Drug Administration Schedule; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Infant; Kaplan-Meier Estimate; Leukemia, Myeloid; Myelodysplastic Syndromes; Prognosis; Proportional Hazards Models; Remission Induction; Young Adult | 2009 |
Thioguanine pharmacokinetics in induction therapy of children with acute myeloid leukemia.
Topics: Administration, Oral; Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Down Syndrome; Doxorubicin; Drug Administration Schedule; Drug Monitoring; Erythrocytes; Etoposide; Female; Guanine Nucleotides; Humans; Infant; Infusions, Intravenous; Leukemia, Myeloid, Acute; Male; Registries; Scandinavian and Nordic Countries; Thioguanine; Thionucleotides; Treatment Outcome | 2009 |
Favorable survival maintained in children who have myeloid leukemia associated with Down syndrome using reduced-dose chemotherapy on Children's Oncology Group trial A2971: a report from the Children's Oncology Group.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Child; Child, Preschool; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Down Syndrome; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Kaplan-Meier Estimate; Leukemia, Myeloid; Male; Thioguanine; Treatment Outcome | 2012 |
AML patients with Down syndrome have a high cure rate with AML-BFM therapy with reduced dose intensity.
Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Down Syndrome; Etoposide; Female; Humans; Idarubicin; Infant; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid, Acute; Male; Survival Rate; Treatment Outcome | 2005 |
Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials.
Topics: Adolescent; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Cytogenetic Analysis; Daunorubicin; Down Syndrome; Drug Administration Schedule; Etoposide; Female; Humans; Infant; Leukemia, Myeloid; Leukocyte Count; Male; Mitoxantrone; Thioguanine; Treatment Outcome; United Kingdom | 2006 |
Repetitive cycles of high-dose cytarabine are effective for childhood acute myeloid leukemia: long-term outcome of the children with AML treated on two consecutive trials of Tokyo Children's Cancer Study Group.
Topics: Acute Disease; Adolescent; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cytarabine; Disease-Free Survival; Down Syndrome; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Hydrocortisone; Infant; Infections; Japan; Kaplan-Meier Estimate; Leukemia, Myeloid; Male; Methotrexate; Mitoxantrone; Remission Induction; Survival Analysis; Transplantation, Autologous; Transplantation, Homologous; Treatment Outcome; Tretinoin; Vincristine | 2007 |
Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Disease-Free Survival; Down Syndrome; Doxorubicin; Etoposide; Female; Humans; Infant; Leukemia, Megakaryoblastic, Acute; Male; Prospective Studies; Treatment Outcome | 2007 |
An effective chemotherapeutic regimen for acute myeloid leukemia and myelodysplastic syndrome in children with Down's syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Daunorubicin; Disease-Free Survival; Down Syndrome; Etoposide; Female; Humans; Infant; Leukemia, Megakaryoblastic, Acute; Leukemia, Myeloid, Acute; Male; Myelodysplastic Syndromes; Probability; Remission Induction; Survival Rate; Time Factors; Treatment Outcome | 2000 |
16 other study(ies) available for etoposide and Down Syndrome
| Article | Year |
|---|---|
Looking up for AML in Down syndrome.
Topics: Cytarabine; Down Syndrome; Etoposide; Humans; Leukemia, Myeloid, Acute | 2017 |
Successful Use of EPOCH-R in 2 Young Adult Patients With Burkitt Lymphoma and Acute Kidney Injury: A Case Report.
Topics: Acute Kidney Injury; Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Down Syndrome; Doxorubicin; Etoposide; Humans; Male; Prednisone; Prognosis; Rituximab; Vincristine | 2019 |
Efficacy of Ifosfamide-Cisplatin-Etoposide (ICE) Chemotherapy for a CNS Germinoma in a Child With Down Syndrome.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Basal Ganglia; Cisplatin; Cranial Irradiation; Down Syndrome; Etoposide; Germinoma; Humans; Ifosfamide; Magnetic Resonance Imaging; Male; Neutropenia; Paresis; Remission Induction; Supratentorial Neoplasms | 2017 |
Treatment experiences of testicular cancer in Hispanic patients with Down's syndrome at the National Cancer Institute of Mexico.
Topics: Abnormalities, Multiple; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Cisplatin; Combined Modality Therapy; Cryptorchidism; Down Syndrome; Etoposide; Fatal Outcome; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Mexico; Neoplasms, Germ Cell and Embryonal; Orchiectomy; Remission Induction; Retroperitoneal Neoplasms; Seminoma; Testicular Neoplasms; Treatment Outcome; Young Adult | 2008 |
Autologous stem cell transplant in a patient with Down syndrome and relapsed Hodgkin lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Combined Modality Therapy; Cyclophosphamide; Down Syndrome; Doxorubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Ifosfamide; Male; Mesna; Peripheral Blood Stem Cell Transplantation; Prednisone; Procarbazine; Recurrence; Remission Induction; Transplantation Conditioning; Transplantation, Autologous; Vinblastine; Vincristine; Vinorelbine | 2009 |
Down syndrome fibroblasts and mouse Prep1-overexpressing cells display increased sensitivity to genotoxic stress.
Topics: Animals; Apoptosis; bcl-X Protein; Cells, Cultured; Down Syndrome; Embryonal Carcinoma Stem Cells; Etoposide; Fibroblasts; Genetic Vectors; Homeodomain Proteins; Humans; Mice; Phenotype; Transcription, Genetic; Tumor Suppressor Protein p53; Ultraviolet Rays | 2010 |
Transient abnormal myelopoiesis in a cytogenetically normal neonate.
Topics: Antineoplastic Agents; Cytarabine; Cytogenetic Analysis; Down Syndrome; Etoposide; Exons; GATA1 Transcription Factor; Humans; Infant, Newborn; Karyotyping; Mutation; Myelopoiesis; Myeloproliferative Disorders | 2010 |
A unique role of GATA1s in Down syndrome acute megakaryocytic leukemia biology and therapy.
Topics: Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytarabine; Daunorubicin; Down Syndrome; Down-Regulation; Etoposide; GATA1 Transcription Factor; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Interleukin-1alpha; Lentivirus; Leukemia, Megakaryoblastic, Acute; Megakaryocytes; Proto-Oncogene Proteins c-bcl-2; RNA, Small Interfering | 2011 |
Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93.
Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Bacteria; Child; Child, Preschool; Clinical Trials as Topic; Cytarabine; Down Syndrome; Etoposide; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Infant; Infant, Newborn; Leukemia, Myeloid; Male; Mitoxantrone; Neutropenia; Prospective Studies; Retrospective Studies; Thioguanine | 2004 |
Etoposide pharmacokinetics in children treated for acute myeloid leukemia.
Topics: Adolescent; Alanine Transaminase; Antineoplastic Agents, Phytogenic; Child; Child, Preschool; Down Syndrome; Etoposide; Female; Humans; Infant; Male; Metabolic Clearance Rate; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2006 |
Acute myelogenous leukemia in Down's syndrome: report of a single pediatric institution using a BFM treatment strategy.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Argentina; Bone Marrow Cells; Child, Preschool; Cytarabine; Down Syndrome; Etoposide; Female; Humans; Idarubicin; Infant; Karyotyping; Leukemia, Myeloid, Acute; Male; Retrospective Studies; Treatment Outcome | 1998 |
Trisomy 21 associated transient neonatal myeloproliferation in the absence of Down's syndrome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosomes, Human, Pair 6; Cytarabine; Down Syndrome; Etoposide; Female; Hematopoietic Stem Cells; Humans; In Situ Hybridization, Fluorescence; Infant, Newborn; Karyotyping; Male; Mitoxantrone; Myeloproliferative Disorders; Time Factors | 1998 |
Cellular cytotoxic drug sensitivity in children with acute leukemia and Down's syndrome: an explanation to differences in clinical outcome?
Topics: Antineoplastic Agents; Blast Crisis; Cell Survival; Child; Cytarabine; Dexamethasone; Down Syndrome; Doxorubicin; Etoposide; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thioguanine; Treatment Outcome; Tumor Cells, Cultured | 2000 |
Plasma pharmacokinetics of etoposide (VP-16) after i.v. administration to children.
Topics: Adolescent; Adult; Antineoplastic Agents, Phytogenic; Area Under Curve; Child; Child, Preschool; Down Syndrome; Etoposide; Female; Humans; Infant; Injections, Intravenous; Male | 2000 |
Different drug sensitivity profiles of acute myeloid and lymphoblastic leukemia and normal peripheral blood mononuclear cells in children with and without Down syndrome.
Topics: Amsacrine; Anthracyclines; Antineoplastic Agents; Busulfan; Cell Survival; Child; Child, Preschool; Cytarabine; Down Syndrome; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Etoposide; Female; Humans; Infant; Leukemia, Myeloid, Acute; Male; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Thioguanine; Vincristine | 2002 |
Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498.
Topics: Acute Disease; Adolescent; Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Azacitidine; Child; Chromosome Aberrations; Chromosome Disorders; Cytarabine; Daunorubicin; Down Syndrome; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Myeloid; Male; Mercaptopurine; Methotrexate; Prednisone; Remission Induction; Thioguanine; Vincristine | 1992 |